BBH icon

VanEck Biotech ETF
BBH

Overview Fund Activity

108 hedge funds and large institutions have $132M invested in VanEck Biotech ETF in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 14 increasing their positions, 39 reducing their positions, and 17 closing their positions.

Holders
108
Holders Change
-6
Holders Change %
-5.26%
% of All Funds
1.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
14
Reduced
39
Closed
17
Calls
–
Puts
$233K
Net Calls
-$233K
Net Calls Change
-$1.01M

Top Buyers

1
JPMorgan Chase & Co
1
JPMorgan Chase & Co
New York
$11.3M
2
CAN
2
Cetera Advisor Networks
California
$1.05M
3
Bank of America
3
Bank of America
North Carolina
$9.67M
4
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$5.39M
5
TRCT
5
Tower Research Capital (TRC)
New York
$744K

Top Sellers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$669K
2
Goldman Sachs
2
Goldman Sachs
New York
$15.4M
3
LFASL
3
Lugano Financial Advisors SA (LFA)
Switzerland
$29K
4
WANY
4
Wealthspire Advisors (New York)
New York
$715K
5
Commonwealth Equity Services
5
Commonwealth Equity Services
Massachusetts
$3.11M
Name Market Value Shares Shares
Change 		Shares
Change %
CA
126
CoreCap Advisors
Michigan
$0 3 +3 New
2 3 4 5
6